Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma | Cell and Developmental Biology
Imugex
c-MET receptor tyrosine kinase as a molecular target in advanced hepat | JHC
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification - Annals of Oncology
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - Journal of Thoracic Oncology
c-MET amplification upregulated PD-L1 expression in EGFR-TKI resistant... | Download Scientific Diagram
Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer? - ScienceDirect
MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregula | OTT
The role of MET in chemotherapy resistance | Oncogene
c-Met Proto-oncogene | Targeting Overexpression
CytoCell C-MET (MET) Amplification FISH Probe | OGT
Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma | Cell and Developmental Biology
c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas - Journal of Thoracic Oncology
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities | Molecular Cancer | Full Text
Targeting the MET Pathway for Lung Cancer Treatments, Biomarkers
C-Met - Wikipedia
Cancers | Free Full-Text | Activated HGF-c-Met Axis in Head and Neck Cancer | HTML
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges | Nature Reviews Clinical Oncology
Targeting the MET Pathway for Lung Cancer Treatments, Biomarkers
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy | Nature Reviews Cancer
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
